21
Participants
Start Date
October 31, 1987
Primary Completion Date
May 31, 2002
Study Completion Date
May 31, 2002
High-dose chemotherapy
Cyclophosphamide 500 mg/m2 IV day 1; Doxorubicin 30 mg/m2 IV Day 1; Methotrexate 300 mg/m2 IV Day 8;5-FU 500 mg/m2 IV day 8; leucovorin 20 mg po q 6 h x 6 doses, day 9- cycles repeated q 21 days
University of Oklahoma Health Sciences Center, Oklahoma City
University of Oklahoma
OTHER